How To Buy Loncar Cancer Immunotherapy ETF (CNCR) Stock

16.62 ↑0.17 (1.03%)
As of March 28, 2024, 3:33pm EST.

How To Buy CNCR

Loncar Cancer Immunotherapy ETF (CNCR) is an ETF listed on the NASDAQ exchange, which means you can buy the stock from most online brokers. Follow the steps below to learn how to purchase shares of CNCR.

  1. Find a reliable broker.

    Don't worry, it's easy and free to open a brokerage account. Below are our favorite brokers where you can buy Loncar Cancer Immunotherapy ETF from:

    View All Recommended Brokers
  2. Fund your new account.

    You'll need to transfer money into your new brokerage account before you can buy the stock. Transferring via a bank transfer is recommended and the most common way to fund an account. Some brokers might allow funding via a debit or credit card.

  3. Search for CNCR.

    When your funds are settled into your account, look for Loncar Cancer Immunotherapy ETF on your broker by searching for the company name: Loncar Cancer Immunotherapy ETF or the ticker symbol: CNCR.

  4. Buy the stock.

    Once that you've found Loncar Cancer Immunotherapy ETF on your broker, submit a purchase order to buy shares of the stock (currently $16.62 a share). Depending on when you purchase, the stock might be higher or lower than the price listed. You may also be able to purchase fractional shares depending on your broker.

    Once your order gets fulfilled, you've purchased your first shares of Loncar Cancer Immunotherapy ETF.

    Tips When Buying

    When submitting your order, you may choose to buy shares of Loncar Cancer Immunotherapy ETF at the market price with a market order or at a set price using a limit order.

    • Market order: Buys the stock immediately at its current price.
    • Limit order: Buys the stock only once it reaches your target price.

    By default all purchases are considered market orders unless specified otherwise. Limit orders are great for when you only want to buy shares of CNCR at a specific price.

Should You Buy CNCR Stock Now?

In the past week the price per share of Loncar Cancer Immunotherapy ETF has gone up ↑0.73 (4.59%) while the daily volume has dropped by more than half. You should buy CNCR now if you think the stock will continue going up in price.

In the end, you should be comfortable with the risk of the investment and only buy shares of CNCR when you feel the time is right.

CNCR Stock Performance

Your browser does not support this chart.

  • Current price: $16.62
  • Yesterday's price: $16.45
  • Price Change (Last 24 Hours): ↑0.17 (1.03%)
  • Price Change (Last 14 Days): ↑0.63 (3.94%)
Buy Now